Velcade
Replacement
|
Medicines
|
18/11/2010
The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles after reconstitution of the product, which occurred in two batches of this medicinal speciality, the three above mentioned batches will be recalled as a precautionary measure and immediate replacement or
a credit note can be provided.
| Name of the medicinal product | VELCADE 3,5 mg Pulver zur Herstellung einer Injektionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/04/274/001 |
| Marketing authorisation holder | Janssen-Cilag International NV Austausch durchgeführt durch Janssen-Cilag Pharma GmbH |
| Batch number(s) | 8EZSQ00, 9FZSK00, 9JZSV00 |
| Classification of the recall | 2 |
Further inquiry note
Page last modified:
12/07/2022